The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized DNA neoantigen vaccine in combination with plasmid IL-12 for the treatment of a patient with anaplastic astrocytoma.
 
Tanner Michael Johanns
Consulting or Advisory Role - Geneos; Novocure
 
Alfredo Perales-Puchalt
Employment - Geneos; Inovio Pharmaceuticals
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Globus; IgM Biosciences; Merck; Pfizer; Vanda Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Methods and compositions for treating cancer - WO2016054153A1 Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR) - WO2018044929A1 (Inst)
 
Roger Stupp
Employment - Novartis (I)
Honoraria - Zai Lab
Consulting or Advisory Role - Bayer Schering Pharma; Celgene; Celularity; CranioVation; FORMA Therapeutics; GT Medical Technologies; Hemispherian; InSightec; Northwest Biotherapeutics; Tocagen; Triact Therapeutics; Zai Lab
Speakers' Bureau - CarThera
Research Funding - CarThera
Travel, Accommodations, Expenses - Novocure
 
Mitchel Berger
No Relationships to Disclose
 
William E. Gillanders
Research Funding - AstraZeneca
 
Chris Miller
No Relationships to Disclose
 
Jasreet Hundal
No Relationships to Disclose
 
Michael D. McLellan
No Relationships to Disclose
 
S. Peter Goedegebuure
No Relationships to Disclose
 
Sarah Rochestie
Employment - Geneos
 
Neil Cooch
Employment - Geneos
Stock and Other Ownership Interests - Geneos
Travel, Accommodations, Expenses - Geneos
 
Joann Peters
No Relationships to Disclose
 
Gavin P. Dunn
Leadership - ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - Immunovalent Therapeutics
 
Niranjan Sardesai
Employment - BMS (I); Geneos; Merck (I)
Leadership - Geneos
Stock and Other Ownership Interests - BMS (I); Geneos; Inovio Pharmaceuticals; Merck (I)
Patents, Royalties, Other Intellectual Property - I am an inventor on several patents assigned to my current and former employers Geneos Therapeutics and Inovio Pharmaceuticals respectively. As these are assigned to the company I receive no royalties or will receive no royalties on these patents.